Chairman and CEO of Lemaitre Vascular Inc (30-Year Financial, Insider Trades) George W Lemaitre (insider trades) sold 28,308 shares of LMAT on 11/05/2019 at an average price of $34.58 a share. The total sale was $978,891.
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. LeMaitre Vascular Inc has a market cap of $677.380 million; its shares were traded at around $34.13 with a P/E ratio of 35.93 and P/S ratio of 6.24. The dividend yield of LeMaitre Vascular Inc stocks is 0.95%. LeMaitre Vascular Inc had annual average EBITDA growth of 29.30% over the past five years. GuruFocus has detected 2 severe warning signs with LeMaitre Vascular Inc. .
CEO Recent Trades:
- Chairman and CEO, 10% Owner George W Lemaitre sold 28,308 shares of LMAT stock on 11/05/2019 at the average price of $34.58. The price of the stock has decreased by 1.3% since.
- Chairman and CEO, 10% Owner George W Lemaitre sold 20,934 shares of LMAT stock on 10/31/2019 at the average price of $35.56. The price of the stock has decreased by 4.02% since.
- Chairman and CEO, 10% Owner George W Lemaitre sold 14,416 shares of LMAT stock on 10/28/2019 at the average price of $36.33. The price of the stock has decreased by 6.06% since.
Directors and Officers Recent Trades:
- President and Director David B Roberts sold 12,202 shares of LMAT stock on 10/28/2019 at the average price of $35.29. The price of the stock has decreased by 3.29% since.
For the complete insider trading history of LMAT, click here
.
